Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension [NA]

View source ↗

Summary

A clinical trial evaluating minimal hepatic encephalopathy in patients with cirrhosis and portal hypertension has completed enrollment/status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: IHU Strasbourg | Conditions: Cirrhosis, Portal Hypertension | NA | Status: COMPLETED